March 22, 2017. We strongly support USPSTF’s ongoing effort to provide screening guidances based on quality, up-to-date scientific studies. We recommend a very careful selection of exclusion populations and studies in order to have a thorough review that allows the USPSTF to develop the most informed recommendations possible.
Read More »We’re Speaking Out on Health Issues
NCHR scientists and health policy experts provide written and oral statements on a wide range of topics.
Here are many of the ways we have been Speaking Out on Health Policy Issues for the last few years. Whether the topic is legislation intended to cure diseases, proposed bans on BPA or other chemicals that disrupt your hormones, the importance of including women, people of color, and patients over 65 in clinical trials, or many other topics, you’ll gain a better understanding of our evidence-based analyses by reading these letters, statements, and testimony.
Here are the ways we have been Speaking out on Medical Treatments and Products, such as prescription drugs and medical devices that the FDA is considering approving, or is considering taking off the market because of serious risks. Whether the topic is Chantix, Addyi, Yaz, Essure, or medical products you’ve never heard of, you can find out more about what is known and not known about the safety and effectiveness of a wide range of products by looking through this section of our website.
NCHR Comment on the USPSTF’s Draft Recommendations for HIV Infection Screening in Nonpregnant Adolescents and Adults
March 22, 2017. We strongly support USPSTF’s ongoing effort to provide screening guidances based on quality, up-to-date scientific studies. We recommend a very careful selection of exclusion populations and studies in order to have a thorough review that allows the USPSTF to develop the best informed recommendations possible.
Read More »NCHR Comment to EPA on Procedures for Prioritization of Chemical for Risk Evaluation
Stephanie Fox-Rawlings, March 20 2017: The National Center for Health Research is advising the EPA to be careful when deciding which chemicals are low-risk. They emphasize that without enough information, some substances might be wrongly considered safe, potentially putting people’s health at risk.
Read More »NCHR Testimony on Labeling and Misuse of Peroxide-Based Contact Lens Products
March 17, 2017. NCHR feels that the only way to avoid misuse and accidents with peroxide-based contact lens solution is to only make these products available behind the counter.
Read More »NCHR Comment to EPA Regarding Risk Evaluation Scoping Effort Under TSCA for Ten Chemical Substances
March 15, 2017. We strongly support efforts of the Environmental Protection Agency (EPA) to improve chemical review, as required by the 2016 Frank H. Lautenberg Chemical Safety for the 21st Century Act. These first 10 chemical evaluations will set a precedent for future evaluations under this law. Therefore, it is imperative that the EPA adequately and appropriately evaluate these chemicals using sufficient, high quality information on harms, exposure, and conditions of use to evaluate the risks these chemicals pose to health.
Read More »